Vascular Clinical Trials
The Division of Vascular Surgery is committed to improving treatments for patients with vascular disease. Researchers investigate minimally invasive treatment options and participate in national clinical trials to both bring new options to current patients and improve the outcomes for future patients.
Thoracic Side Branch Graft Trial
The University of Maryland's Center for Aortic Disease is participating in a trial to determine whether the GORE® TAG® Thoracic Branch Endoprosthesis is safe and effective in treating lesions of the aortic arch and descending thoracic aorta. Robert Crawford, MD, is a principal investigator.
Learn more about the Thoracic Branch trial.
A new registry will oversee the credentialing process for physicians and clinical centers interested in performing carotid artery stenting as part of the CREST-2 clinical trial. Brajesh K. Lal, MD, at the University of Maryland School of Medicine is the leader of this national CREST-2 Registry, known as C2R.
The C2R will evaluate hospitals and physicians across the country for their ability to perform carotid artery stenting. Committees within C2R will identify clinical centers and doctors that have the quality, resources, expertise, and clinical volume to be high-quality performers of carotid stenting. The University of Maryland was a natural leader for this registry based on its experience performing carotid stenting on appropriate patients throughout the mid-Atlantic.
Learn more about the CREST-2 Registry.
For patient inquiries, call 410-328-5840.